Neurodegenerative diseases are one of the largest medical challenges of our time. Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development.
The Time is Right
Recent groundbreaking scientific insights into the genetic causes and biological processes underlying neurodegenerative diseases offer an unprecedented opportunity for the discovery and development of effective medicines for Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases.
Advances in the genetics, pathology and cell biology underlying chronic neurodegenerative disease have identified pathways that trigger neurodegeneration and contribute to disease onset and progression. Denali is applying deep scientific and drug development expertise to fully harvest the potential of these pathways in order to discover effective molecular therapeutics.
The programs in our portfolio are based on our deep expertise in the biology of neurodegenerative diseases and the blood-brain barrier. Our core portfolio currently consists of programs at various stages of clinical and preclinical development and have the potential to meaningfully improve the lives of patients by directly addressing a cause or risk factor for the disease.
We are a team dedicated to defeating degeneration. We are passionate about solving problems with rigorous science and translational medicine. We have joined together to discover and develop therapies that will change the lives of patients suffering from neurodegenerative disease.
Defeating degeneration is only possible through teamwork and collaboration. Partnering is a central part of our strategy and we are continuously on the lookout for new assets, technologies, and scientific insights.
With a team of experienced and passionately dedicated scientists and drug developers, we believe we can succeed in meaningfully improving the lives of patients and their families. Follow the link to learn how you can contribute to this mission.
Our goal is to discover and develop therapeutics to defeat degeneration. We have assembled a team with deep scientific, clinical, business, and leadership expertise in biotechnology and specifically in neurodegenerative diseases. We invite you to consider an opportunity with Denali to help achieve our goal of delivering meaningful therapeutics to patients.